Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | $179.96M | $153.94M | 39.54% | -$26.02M |
| ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | 4,012,903 | 0 | $42.34M | $50.48M | 12.97% | +$8.15M |
| Mineralys Therapeutics, Inc.(MLYS) | 2,016,822 | 3,127,933 | +1,111,111 | $24.83M | $49.67M | 12.76% | +$24.84M |
| Zenas BioPharma, Inc.(ZBIO) | 4,911,539 | 4,911,539 | 0 | $40.23M | $38.80M | 9.97% | -$1.42M |
| CRISPR Therapeutics AG(CRSP) | 1,048,951 | 1,048,951 | 0 | $41.29M | $35.70M | 9.17% | -$5.59M |
| Design Therapeutics, Inc.(DSGN) | 6,526,476 | 6,526,476 | 0 | $40.27M | $25.19M | 6.47% | -$15.08M |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | $15.40M | $12.03M | 3.09% | -$3.37M |
| Oculis Holding AG(OCS) | 0 | 322,500 | +322,500 | $0 | $6.14M | 1.58% | +$6.14M |
| Nkarta, Inc.(NKTX) | 3,333,333 | 3,333,333 | 0 | $8.30M | $6.13M | 1.58% | -$2.17M |
| Oruka Therapeutics, Inc.(ORKA) | 430,330 | 430,330 | 0 | $8.34M | $4.42M | 1.13% | -$3.93M |
| KALA BIO, Inc.(KALA) | 598,940 | 598,940 | 0 | $4.16M | $3.43M | 0.88% | -$724.7K |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | $4.97M | $3.35M | 0.86% | -$1.62M |